Ocugen said new research points to RORα as a potential multi-pathway target in Alzheimer’s disease, broadening its therapeutic approach. The Frontiers in Neuros

Ocugen said new research points to RORα as a potential multi-pathway target in Alzheimer’s disease, broadening its therapeutic approach. The Frontiers in Neuroscience study examined links to neuroinflammation, oxidative stress, mitochondrial health and circadian regulation.